New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques
New Technologies to Determine Carotid Plaque Vulnerability: A Pilot Study to Assess Contrast-Enhanced Ultrasound (CEUS) and Shear Wave Elastography (SWE) in Patients With Significant Carotid Plaques
Sponsor: Mayo Clinic
Listed as NCT03335033, this PHASE2 trial focuses on Carotid Artery Plaque and remains completed. Sponsored by Mayo Clinic, it has been updated 14 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jul 2024 [monthly]
Completed PHASE2
-
Sep 2022 — Dec 2022 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Feb 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
▶ Show 9 earlier versions
-
Sep 2021 — Feb 2022 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2
-
Jun 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Mar 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE2
-
Feb 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE2
-
Jan 2018 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Dec 2017 — Jan 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Nov 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .